Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints. [electronic resource]
- Oncogene Feb 1998
- 721-36 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0950-9232
10.1038/sj.onc.1201793 doi
Animals Ataxia Telangiectasia--pathology Ataxia Telangiectasia Mutated Proteins CDC2 Protein Kinase--metabolism CDC2-CDC28 Kinases CHO Cells Cell Cycle Proteins Cells, Cultured Cricetinae Cyclin E Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinase Inhibitor p21 Cyclin-Dependent Kinases--metabolism Cyclins--metabolism DNA--biosynthesis DNA Replication--radiation effects DNA-Binding Proteins Fibroblasts--cytology G1 Phase Gene Deletion Humans Mice Mice, Inbred C57BL Mice, Knockout Protein Kinases--metabolism Protein Serine-Threonine Kinases--metabolism Proteins--metabolism S Phase Signal Transduction Tumor Suppressor Protein p53--genetics Tumor Suppressor Proteins